Influenza H1N1 Immunogenicity study

Phase 4

Completed

• Conditions: 10047438; Influenza; flu

• Registration Number: NL-OMON32857
• Lead Sponsor: Sint Elisabeth Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 200

Inclusion Criteria

All the subjects are between 18 and 65 years of age

Exclusion Criteria

none

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The study parameters for humoral immune response are<br /><br>hemagglutination-inhibition antibodies titers. Sera will be analyzed by a<br /><br>hemagglutination-inhibition (HAI) test, according to standard procedures.<br /><br>The induction of cellular immunity will be measured according to Bodewes et al.<br /><br>(11) and will take place at the Erasmus Medical Center, Rotterdam.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>none</p><br>